Antipsychotic and Antidepressant Drug Use in the Elderly and the Risk of Venous Thromboembolism
- 1 January 2002
- journal article
- in focus
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 88 (08) , 205-209
- https://doi.org/10.1055/s-0037-1613188
Abstract
Summary: Preliminary evidence suggests that use of antipsychotic drugs is associated with an increased risk of venous thromboembolism.To evaluate the relationship between antipsychotic or antidepressant drug use and venous thromboembolism among adults aged 65 years and older.Retrospective cohort study using linked health care administrative databases over a nine year period.The entire province of Ontario, Canada.Individuals aged 65 years and over exclusively prescribed either antipsychotic drugs (n = 22514), antidepressant drugs (n = 75649) or thyroid replacement hormones (33033), the referent control group. We excluded those with an antecedent history of cardiovascular disease, venous thromboembolism or cancer, as well as those dispensed warfarin before study entry.Diagnosis of deep vein thrombosis or pulmonary embolism.Relative to those prescribed thyroid hormones, neither anti-depressant (adjusted hazard ratio 1.02, 95% CI 0.91-1.14) nor anti-psychotic (adjusted hazard ratio 1.13, 95% CI 0.96-1.32) drug use was associated with an increased risk for deep vein thrombosis. Similar risk estimates were found for deep vein thrombosis or pulmonary embolism. In a sub-group analysis, only butyrophenone use was found to be associated with a slightly increased risk of deep vein thrombosis (adjusted HR 1.51, 95% CI 1.23-1.86) as well as deep vein thrombosis or pulmonary embolism (adjusted HR 1.43, 95% CI 1.18-1.74).In a large cohort of adults aged 65 years and older, neither antipsychotic or antidepressant drug use was associated with an increased risk of venous thromboembolism, with the exception of a slightly increased risk among those prescribed butyrophenones. Further data are required before use of these psychoactive drugs can be considered a risk factor for venous thromboembolism.Keywords
Funding Information
- Thrombosis Research
- University Health Network
- Institute for Health Economics
This publication has 18 references indexed in Scilit:
- Antipsychotic medication and venous thrombosisThe British Journal of Psychiatry, 2001
- Determinants for the use of psychotropics among nursing home residentsInternational Journal of Geriatric Psychiatry, 2001
- Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyThe Lancet, 2000
- Frailty Bias in Comorbidity Risk Adjustments of Community-Dwelling Elderly PopulationsJournal of Clinical Epidemiology, 1999
- Comorbidity and Drug Use in Cognitively Impaired Elderly Living in Long-Term CareDementia and Geriatric Cognitive Disorders, 1998
- 2 Diagnostic management of venous thromboembolismBailliere's Clinical Haematology, 1998
- Two Cases of Deep Vein Thrombosis Associated with a Combined Paroxetine and Zotepine TherapyPharmacopsychiatry, 1997
- Risk Factors Associated with ImmobilityJournal of the American Geriatrics Society, 1988
- Deep-vein thrombosis with antipsychotic drugsPsychosomatics, 1983
- Thromboembolische Komplikationen bei neuro- und thymoleptischer BehandlungDeutsche Medizinische Wochenschrift (1946), 1967